These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16613541)
1. The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer. Dooms CA; Pat KE; Vansteenkiste JF Expert Rev Anticancer Ther; 2006 Apr; 6(4):531-44. PubMed ID: 16613541 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigms. Socinski MA Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4210s-4214s. PubMed ID: 15217960 [TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer. Fallowfield LJ; Harper P Lung Cancer; 2005 Jun; 48(3):365-77. PubMed ID: 15893006 [TBL] [Abstract][Full Text] [Related]
4. New developments in chemotherapy for advanced non-small cell lung cancer. Raez LE; Lilenbaum R Curr Opin Oncol; 2006 Mar; 18(2):156-61. PubMed ID: 16462185 [TBL] [Abstract][Full Text] [Related]
5. [Assessment of the quality of life of cancer patients. The preliminary applications to advanced bronchial cancers]. Belpomme D; Le Rol A; Pappo F; Bernheim J; Dautzenberg B; Brechot JM; Chastang C; Guerin RA Bull Cancer; 1986; 73(5):627-33. PubMed ID: 3022852 [TBL] [Abstract][Full Text] [Related]
6. Quality of life assessment in chemotherapy trials for non-small cell lung cancer: are theory and practice significantly different? Hopwood P Semin Oncol; 1996 Oct; 23(5 Suppl 10):60-4. PubMed ID: 8893884 [TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Jiang J; Liang X; Zhou X; Huang R; Chu Z Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer. Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711 [TBL] [Abstract][Full Text] [Related]
9. Quality-of-life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of life. Gralla RJ Oncologist; 2004; 9 Suppl 6():14-24. PubMed ID: 15616146 [TBL] [Abstract][Full Text] [Related]
10. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy. Hotta K; Fujiwara Y; Matsuo K; Suzuki T; Kiura K; Tabata M; Takigawa N; Ueoka H; Tanimoto M Cancer; 2007 Mar; 109(5):939-48. PubMed ID: 17285602 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic options for elderly patients with advanced non-small cell lung cancer. Avery EJ; Kessinger A; Ganti AK Cancer Treat Rev; 2009 Jun; 35(4):340-4. PubMed ID: 19155139 [TBL] [Abstract][Full Text] [Related]
13. Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancer. Park JO; Kim SW; Ahn JS; Suh C; Lee JS; Jang JS; Cho EK; Yang SH; Choi JH; Heo DS; Park SY; Shin SW; Ahn MJ; Lee JS; Yun YH; Lee JW; Park K J Clin Oncol; 2007 Nov; 25(33):5233-9. PubMed ID: 18024869 [TBL] [Abstract][Full Text] [Related]
14. Sequential, alternating, and maintenance/consolidation chemotherapy in advanced non-small cell lung cancer: a review of the literature. Grossi F; Aita M; Follador A; Defferrari C; Brianti A; Sinaccio G; Belvedere O Oncologist; 2007 Apr; 12(4):451-64. PubMed ID: 17470688 [TBL] [Abstract][Full Text] [Related]
15. The role of maintenance chemotherapy in advanced nonsmall cell lung cancer. Jalal SI; Ademuyiwa FO; Hanna NH Curr Opin Oncol; 2009 Mar; 21(2):110-5. PubMed ID: 19532011 [TBL] [Abstract][Full Text] [Related]
16. Early-stage NSCLC: the role of radiotherapy and systemic therapy. Bunn PA J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S31-40. PubMed ID: 19780244 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for lung cancer: the state of the art in 2009. Higgins MJ; Ettinger DS Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996 [TBL] [Abstract][Full Text] [Related]
18. Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Johnson EA; Marks RS; Mandrekar SJ; Hillman SL; Hauge MD; Bauman MD; Wos EJ; Moore DF; Kugler JW; Windschitl HE; Graham DL; Bernath AM; Fitch TR; Soori GS; Jett JR; Adjei AA; Perez EA Lung Cancer; 2008 May; 60(2):200-7. PubMed ID: 18045731 [TBL] [Abstract][Full Text] [Related]
19. Survival among patients with platinum resistant, locally advanced non-small cell lung cancer treated with platinum-based systemic therapy. d'Amato TA; Pettiford BL; Schuchert MJ; Parker R; Ricketts WA; Luketich JD; Landreneau RJ Ann Surg Oncol; 2009 Oct; 16(10):2848-55. PubMed ID: 19609620 [TBL] [Abstract][Full Text] [Related]
20. Measurement and management of health-related quality of life in lung cancer. Davis K; Yount S; Wagner L; Cella D Clin Adv Hematol Oncol; 2004 Aug; 2(8):533-40. PubMed ID: 16163227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]